Eli Lilly Valuation

LLY Stock   28.58  0.32  1.13%   
Eli Lilly shows a prevailing Real Value of USD29.69 per share. The current price of the firm is USD28.58. Our model computes the value of Eli Lilly from reviewing the firm technical indicators and probability of bankruptcy. In general, investors advise obtaining undervalued stocks and abandoning overvalued stocks since, at some point, stock prices and their ongoing real values will submerge.
Fairly Valued
Today
28.58
Please note that Eli Lilly's price fluctuation is very steady at this time. Calculation of the real value of Eli Lilly is based on 3 months time horizon. Increasing Eli Lilly's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Eli Lilly is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eli Stock. However, Eli Lilly's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  28.58 Real  29.69 Hype  28.42 Naive  26.2
The intrinsic value of Eli Lilly's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eli Lilly's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
29.69
Real Value
31.65
Upside
Estimating the potential upside or downside of Eli Lilly and helps investors to forecast how Eli stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eli Lilly more accurately as focusing exclusively on Eli Lilly's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
28.1128.5829.05
Details
Hype
Prediction
LowEstimatedHigh
26.4628.4230.38
Details
Naive
Forecast
LowNext ValueHigh
24.2426.2028.16
Details

Eli Lilly Total Value Analysis

Eli Lilly and is now estimated to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Eli Lilly fundamentals before making investing decisions based on enterprise value of the company

Eli Lilly Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Eli suggests not a very effective usage of assets in December.

About Eli Lilly Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Eli Lilly and. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Eli Lilly based exclusively on its fundamental and basic technical indicators. By analyzing Eli Lilly's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Eli Lilly's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eli Lilly. We calculate exposure to Eli Lilly's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Eli Lilly's related companies.
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.